Literature DB >> 20170982

Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit.

A Kohlenberg1, D Weitzel-Kage, P van der Linden, D Sohr, S Vögeler, A Kola, E Halle, H Rüden, K Weist.   

Abstract

Infection control personnel performing surveillance activities noticed a cluster of patients with isolates of carbapenem-resistant Pseudomonas aeruginosa (CRPA) in the surgical intensive care unit (SICU) of a German University Hospital. An outbreak investigation including a descriptive analysis, a case-control study comparing 15 CRPA case patients with 18 patients with carbapenem-susceptible P. aeruginosa, environmental sampling and pulsed-field gel electrophoresis (PFGE) typing of P. aeruginosa isolates was carried out. Fifteen patients acquired CRPA in the SICU during the outbreak period between 1 July 2006 and 31 October 2006 and PFGE typing of 11 available patient isolates revealed two outbreak strains as well as sporadic CRPA isolates. Both outbreak strains were resistant to penicillins, cephalosporins, carbapenems, aminoglycosides and quinolones, and remained susceptible only to colistin. The most likely mode of transmission was cross-transmission between patients during postoperative wound care with abdominal and/or thoracic drains (odds ratio: 64.33; 95% confidence interval: 5.32-999) and therapy with quinolones (48.37; 3.71-999) being independent risk factors for acquisition of CRPA. No further clusters of CRPA cases were observed after implementation of contact isolation precautions and after healthcare workers were made aware of the likely mode of transmission. This study shows the complex epidemiology of CRPA in a SICU including cross-transmission of two CRPA strains related to postoperative wound care. Copyright (c) 2009 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20170982     DOI: 10.1016/j.jhin.2009.10.024

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  12 in total

Review 1.  Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations.

Authors:  Fereshteh Ezadi; Abdollah Ardebili; Reza Mirnejad
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

2.  Strategies to prevent surgical site infections in acute care hospitals: 2014 update.

Authors:  Deverick J Anderson; Kelly Podgorny; Sandra I Berríos-Torres; Dale W Bratzler; E Patchen Dellinger; Linda Greene; Ann-Christine Nyquist; Lisa Saiman; Deborah S Yokoe; Lisa L Maragakis; Keith S Kaye
Journal:  Infect Control Hosp Epidemiol       Date:  2014-06       Impact factor: 3.254

Review 3.  The spread of carbapenemase-producing bacteria in Africa: a systematic review.

Authors:  Rendani I Manenzhe; Heather J Zar; Mark P Nicol; Mamadou Kaba
Journal:  J Antimicrob Chemother       Date:  2014-09-26       Impact factor: 5.790

4.  Pseudo-outbreak of extremely drug-resistant pseudomonas aeruginosa urinary tract infections due to contamination of an automated urine analyzer.

Authors:  M Hallin; A Deplano; S Roisin; V Boyart; R De Ryck; C Nonhoff; B Byl; Y Glupczynski; O Denis
Journal:  J Clin Microbiol       Date:  2012-01-04       Impact factor: 5.948

5.  Presence of qacEΔ1 gene and susceptibility to a hospital biocide in clinical isolates of Pseudomonas aeruginosa resistant to antibiotics.

Authors:  Célia Romão; Catia Aparecida Miranda; Jaqueline Silva; Maysa Mandetta Clementino; Ivano de Filippis; Marise Asensi
Journal:  Curr Microbiol       Date:  2011-04-12       Impact factor: 2.188

Review 6.  A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa.

Authors:  Anne F Voor In 't Holt; Juliëtte A Severin; Emmanuel M E H Lesaffre; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

7.  Sialylation of outer membrane porin protein D: a mechanistic basis of antibiotic uptake in Pseudomonas aeruginosa.

Authors:  Biswajit Khatua; Jeremy Van Vleet; Biswa Pronab Choudhury; Rama Chaudhry; Chitra Mandal
Journal:  Mol Cell Proteomics       Date:  2014-03-18       Impact factor: 5.911

8.  Nosocomial outbreak of imipenem-resistant Pseudomonas aeruginosa producing VIM-2 metallo-β-lactamase in a kidney transplantation unit.

Authors:  S Hammami; I Boutiba-Ben Boubaker; R Ghozzi; M Saidani; S Amine; S Ben Redjeb
Journal:  Diagn Pathol       Date:  2011-10-28       Impact factor: 2.644

9.  Difficult-to-detect carbapenem-resistant IMP13-producing P. aeruginosa: experience feedback concerning a cluster of urinary tract infections at a surgical clinic in France.

Authors:  Odile Milan; Laurent Debroize; Xavier Bertrand; Patrick Plesiat; Anne-Sophie Valentin; Roland Quentin; Nathalie Van der Mee-Marquet
Journal:  Antimicrob Resist Infect Control       Date:  2013-04-04       Impact factor: 4.887

10.  An outbreak of extremely drug-resistant Pseudomonas aeruginosa in a tertiary care pediatric hospital in Italy.

Authors:  Marta Ciofi Degli Atti; Paola Bernaschi; Michaela Carletti; Ida Luzzi; Aurora García-Fernández; Alice Bertaina; Annamaria Sisto; Franco Locatelli; Massimiliano Raponi
Journal:  BMC Infect Dis       Date:  2014-09-10       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.